Study on the Effects of Acupuncture in Patients with Cyclic Mastalgia
CM
1 other identifier
interventional
66
0 countries
N/A
Brief Summary
This study is designed to evaluate the effectiveness of acupuncture in treating cyclic mastalgia (breast pain that occurs in a cyclical pattern, often related to the menstrual cycle). The study will take place at the Pinggu District Traditional Chinese Medicine Hospital in Beijing and also included volunteers who are interested in participating. Sixty-six patients who meet the criteria for cyclic mastalgia will be chosen to take part in the study.The patients will be randomly divided into two groups: Observation Group (Acupuncture Group): 33 patients receive real acupuncture treatments. Control Group (Sham Acupuncture Group): 33 patients receive sham acupuncture treatments. This means that neither the participants nor the researchers know who is receiving the real or fake treatment, ensuring a fair comparison. The study will last for 16 weeks. The main thing researchers look at is the change in daily average overall breast pain. Researchers also observe changes in:Infrared temperature at specific acupoints (Danzhong CV17, Rugen ST18, and Tianzong SI11).Meridian energy values of the Liver, Spleen, and Stomach meridians, which are concepts in Traditional Chinese Medicine related to the flow of energy in the body. This study helps us understand whether acupuncture is an effective treatment for cyclic mastalgia. By comparing real acupuncture to sham acupuncture, researchers can determine if the improvements seen are due to the acupuncture treatment itself or other factors like the placebo effect. What does this mean for patients? If you suffer from cyclic mastalgia, this study provides valuable information about the potential benefits of acupuncture as a treatment option. It's important to discuss any treatment options with your health care provider to determine the best approach for your specific situation. What does this mean for health care providers? This study contributes to the evidence-base for treating cyclic mastalgia with acupuncture. Understanding the results of this study can help health care providers make informed decisions when discussing treatment options with their patients. Overall, this well-designed study offers insights into the use of acupuncture for cyclic mastalgia, which can be beneficial for both patients and health care providers in making informed decisions about treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedFirst Posted
Study publicly available on registry
December 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedDecember 3, 2024
November 1, 2024
6 months
November 24, 2024
November 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
the change in the daily average Visual Analog Scale (VAS) score for overall breast pain
the change in visual analog scale (VAS) of overall breast pain on a daily basis within the first two weeks before the baseline period and the end of treatment.
1 year
Secondary Outcomes (2)
the changes in infrared temperature at the acupoints of Danzhong, Rugen, and Tianzong
1 year
the meridian energy values
1year
Other Outcomes (2)
effectiveness of the acupuncture blinding
1 year
Treatment-Emergent Adverse Events
1year
Study Arms (2)
sham acupuncture group
SHAM COMPARATORIn the SA group, non-penetrating sham acupuncture was applied at 14 specific non-acupuncture points on the back. A pedestal was affixed to each non-acupuncture point. Blunt-tip needles were then inserted into the pedestal at a depth of 3-5 mm, and it was ensured that they only touched the skin without penetration
acupuncture group
EXPERIMENTALthe choice of acupoints was based on the theory of traditional Chinese medicine (TCM), as follows: Ashi point, Tanzhong (CV17), bilateral Wuyi (ST15), Rugen (ST18), Tianzong (SI11), Geshu (BL17), Ganshu (BL18), Hegu (LI4), Sanyinjiao (SP6), and Taichong (LR3).
Interventions
In the sham acupuncture group, sham acupuncture was applied at 14 specific non-acupuncture points on the back.
acupuncture:the choice of acupoints was based on the theory of traditional Chinese medicine (TCM). All needles were manually manipulated to achieve the deqi sensation
Eligibility Criteria
You may not qualify if:
- (1) Received relevant treatment within the past month; (2) with serious cardiovascular and cerebrovascular diseases, severe liver and kidney dysfunction, or coagulation dysfunction; (3)with diseases such as rib cartilage inflammation, chest wall injury, rib fractures, and other external breast pain; (4) in pregnancy or lactation stage; (5)There is a serious skin disease or infection at the intended acupuncture site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chuan Yulead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
November 24, 2024
First Posted
December 3, 2024
Study Start
December 1, 2024
Primary Completion
May 31, 2025
Study Completion
July 31, 2025
Last Updated
December 3, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
After the research is completed on December 31, 2026,it will be made available to others upon request to the person in charge (yuchuan106@126.com), only for research, and non-commercial purposes toindividuals affiliated with academic or public health institutions.